Home Compare ORNBV.HE vs PFE
Stock Comparison · Industry comparison · Drug Manufacturers - General

Orion Oyj vs Pfizer: Which Stock Looks Stronger in 2026?

Orion Oyj holds the cleaner structural position, with the lead spread across profitability and growth. Pfizer still has the edge on valuation, which keeps the comparison from looking entirely one-sided. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The clearest separation starts in profitability, but growth adds another real layer to the result. The overall score gap is 41 points in favour of Orion Oyj.

INDUSTRY COMPARISON

Both operate in: Drug Manufacturers - General

This comparison is based on industry proximity, not on functional trajectory similarity. ORNBV.HE and PFE share the same industry classification.

For a similarity-based comparison, see how Orion Oyj and Pfizer each position within their functional peer groups in AssetNext.

Peer-Relative Score
ORNBV.HE
Orion Oyj
83
Peer-Score
Signal qualityHigh
vs
PFE
Pfizer Inc.
42
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: ORNBV.HE vs PFE Profitability 100 12 Stability 71 48 Valuation 61 82 Growth 100 19 ORNBV.HE PFE
Gap Ranking
#1 Profitability +88
#2 Growth +81
#3 Stability +23
#4 Valuation +21
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for ORNBV.HE and PFE Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer ORNBV.HEPFE Relative valuation Structural strength

Orion Oyj holds the stronger structural profile, but the price setup still leans toward Pfizer Inc..

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
Orion Oyj ranks near the top of the group on profitability; Pfizer Inc. sits in the weaker half.
Growth
On growth, the gap still runs the same way: Orion Oyj sits near the top of the group, while Pfizer Inc. remains in the weaker half.
Profitability — Dominant Gap
ORNBV.HE
100
PFE
12
Gap+88in favour of ORNBV.HE

The profitability lead is mainly driven by a 23.3-point operating margin advantage.

What keeps the gap from being one-sided

Pfizer Inc. still carries lower volatility exposure — that difference is real enough to prevent the comparison from becoming one-sided.

What this means for the comparison

The lead is built on both profitability and growth — though valuation still provides a counterweight.

Explore full peer positioning in AssetNext

Break down the ORNBV.HE vs PFE comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how ORNBV.HE and PFE each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.